CLINICAL_TRIALS
trial_result
· 2010-12-03
Clinical Trial Update: ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults [Phase 3]
Summary
This report presents long-term safety results from a Phase 3 study of VIVITROL (naltrexone extended-release) in adults with alcohol use disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Alcoholism | Phase 3 | Status: COMPLETED | Results posted: 2010-12-03